Incyte Analyst Price Targets

Wall Street analyst price targets and consensus rating for Incyte (INCY).

Price Target Range — 8 Quarters

Analyst Consensus — 23 Analysts

12Buy

11Hold

Consensus RatingBuy# Analysts23Avg. Consensus PT$122Upside to Avg. PT+2.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 2, 2026	Bernstein	Jeffrey Walch	PT Raise	Market Perform	$104→$108
Oct 30, 2026	Wells Fargo	Derek Archila	PT Cut	Equal-Weight	$128→$127
Oct 30, 2026	RBC Capital	Brian Abrahams	PT Raise	Sector Perform	$114→$117
Oct 30, 2026	Barclays	Etzer Darout	PT Raise	Overweight	$139→$143
Oct 30, 2026	Evercore ISI Group	Maneka Mirchandaney	PT Raise	In-Line	$125→$127
Oct 30, 2026	Oppenheimer	Jay Olson	Upgrade	Perform→Outperform	$120→$144
Oct 21, 2026	TD Cowen	Tara Bancroft	PT Raise	Buy	$138→$140
Oct 14, 2026	Truist Securities	Srikripa Devarakonda	PT Raise	Hold	$105→$115
Oct 13, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$152
Oct 8, 2026	RBC Capital	Brian Abrahams	PT Raise	Sector Perform	$109→$114
Oct 5, 2026	Stifel	Stephen Willey	PT Raise	Buy	$145→$157
Oct 1, 2026	Wells Fargo	Derek Archila	PT Raise	Equal-Weight	$116→$128
Sep 28, 2026	JP Morgan	Jessica Fye	PT Raise	Neutral	$120→$123
Sep 28, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	PT Raise	Buy	$150→$152
Sep 22, 2026	RBC Capital	Brian Abrahams	Maintained	Sector Perform	$109
Aug 20, 2026	Canaccord Genuity	John Newman	Initiate	Buy	$152
Aug 20, 2026	HC Wainwright & Co.	Mitchell S. Kapoor	Maintained	Buy	$150
Aug 17, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$110→$130
Aug 4, 2026	Mizuho	Salim Syed	PT Raise	Outperform	$121→$137
Aug 3, 2026	Leerink Partners	Andrew Berens	PT Raise	Outperform	$131→$155